Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 18
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 2 human prescription drug. By marketing category: NDA 2.
| Dosage form | NDCs |
|---|---|
| capsule | 2 |
| Route | NDCs |
|---|---|
| oral | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| secura bio, inc | 2 |
Exclusivity
Patents and exclusivities
18| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 7989494 | FARYDAKpanobinostat lactate | substance, product | Jan 2028 |
| 8883842 | FARYDAKpanobinostat lactate | use | Jun 2028 |
| 9216982 | COPIKTRAduvelisib | use | Jan 2029 |
| 11312718 | COPIKTRAduvelisib | product | Jan 2032 |
| 9840505 | COPIKTRAduvelisib | use | Jan 2032 |
| RE46621 | COPIKTRAduvelisib | substance, product | May 2032 |
| 8193182 | COPIKTRAduvelisib | substance | Sept 2032 |
| 12213983 | COPIKTRAduvelisib | use | Apr 2035 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| COPIKTRA | duvelisib | capsule, oral | 73116-215NDA |
| COPIKTRA | duvelisib | capsule, oral | 73116-225NDA |
Compare
Other companies listing duvelisib
- Catalent Pharma Solutions Inc.22 sites · 261 NDC
Enquiry
Common questions
- Is Secura Bio, Inc FDA approved?
- Secura Bio, Inc holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Secura Bio, Inc make?
- 2 products are listed under Secura Bio, Inc in the openFDA NDC Directory, most often as capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.